Research Topics

Marek Jutel

Summary

Country: Poland

Publications

  1. pmc EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
    Moises A Calderon
    Section of Allergy and Clinical Immunology, Imperial College, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK
    Clin Transl Allergy 2:20. 2012
  2. pmc Recombinant allergens: the present and the future
    Marek Jutel
    Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland
    Hum Vaccin Immunother 8:1534-43. 2012

Collaborators

  • Moises A Calderon
  • Eva M Varga
  • Carmen Moreno
  • Giovanni Pajno
  • Peter Eng
  • Claus Bachert
  • Montserrat Fernandez-Rivas
  • Antonio Nieto
  • Ludger Klimek
  • Jan Lotvall
  • Beatrice Bilo
  • Ralph Mosges
  • Antonella Muraro
  • Rudolph Valenta
  • Aziz Sheikh
  • Roy Gerth van Wijk
  • Glenis Scadding
  • Barbara Bohle
  • Emilio Alvarez-Cuesta
  • Jörg Kleine-Tebbe
  • Alain Didier
  • Bodo Niggemann
  • Giovanni Passalacqua
  • Sabina Rak
  • Erkka Valovirta
  • Johannes C Virchow
  • Stephen R Durham
  • Ronald Dahl
  • Cezmi Akdis
  • Nikolaos Papadopoulos
  • Jocelyne Just
  • Albrecht Bufe
  • Lars Jacobsen
  • Jean Bousquet
  • Walter G Canonica
  • Oliver Pfaar
  • Pascal Demoly
  • Gianenrico Senna
  • Hans J Malling
  • Carmen Vidal
  • Ulrich Wahn
  • Gabriela Senti
  • Victoria Cardona
  • Marianne van Hage
  • Anthony Frew

Detail Information

Publications2

  1. pmc EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
    Moises A Calderon
    Section of Allergy and Clinical Immunology, Imperial College, National Heart and Lung Institute, Dovehouse Street, London, SW3 6LY, UK
    Clin Transl Allergy 2:20. 2012
    ....
  2. pmc Recombinant allergens: the present and the future
    Marek Jutel
    Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland
    Hum Vaccin Immunother 8:1534-43. 2012
    ..They showed high efficacy and safety profile as well as very strong modulation of T and B cell responses to specific allergens...